• Patient Action Center
  • Seniors Rising Now
0 Items
Patients Rising Now
  • Home
  • About
    • About Us
    • Who We Are
    • Partners and Coalitions
    • Corporate Membership
    • Corporate Members
    • Financials
  • Issues
    • 117th Congress Advocacy Scorecard
    • Legislative Positions
    • Terry’s Hot Take
    • News and Insights
    • Positions
    • Policy Supported
  • Take Action
    • Patient Action Center
    • What You Can Do
    • Advocacy Masterclass
  • Donate
Select Page
  • Home
  • About
    • About Us
    • Who We Are
    • Partners and Coalitions
    • Corporate Membership
    • Corporate Members
    • Financials
  • Issues
    • 117th Congress Advocacy Scorecard
    • Legislative Positions
    • Terry’s Hot Take
    • News and Insights
    • Positions
    • Policy Supported
  • Take Action
    • Patient Action Center
    • What You Can Do
    • Advocacy Masterclass
  • Donate

Tag: medicare part D

Comments regarding the CY 2023 Medicare Advantage and Part D Proposed Rule (CMS-4192-P)

Comments regarding the CY 2023 Medicare Advantage and Part D Proposed Rule (CMS-4192-P)

Mar 8, 2022 | Letters Submitted

Patients Rising Now supports to provisions on the proposed rule to lower out of pocket Medicare Part D prescription drug costs and improve transparency, the patient voice, and health equity in Medicare Advantage (MA) and Part D.  Read the Comments Letter   ...
Read more
Statement by Patients Rising Now Executive Director Terry Wilcox on Release of H.R. 3 Drug Pricing Proposal

Statement by Patients Rising Now Executive Director Terry Wilcox on Release of H.R. 3 Drug Pricing Proposal

Sep 20, 2019 | News

H.R. 3 was a long time in being released, but won’t take nearly as long to reject. It fails the central purpose of any drug price reform: Out of pocket relief for patients and ready access to the treatments they need and deserve. It opts instead to create a body...
Read more

Will Divided Government Produce Lower Drug Prices?

Aug 6, 2019 | Drug Costs, Medicare Part D, News

Divided government, as a result of Democrats taking back the House of Representatives in last week’s election, means that almost all legislation will grind to a halt. This is especially true in today’s era of political polarization. But there is one Democratic policy...
Read more

A Health Care Win for Congress: Stop the Medicare Part D Out-of-Pocket Cliff

Aug 6, 2019 | Medicare Part D, News

Better health care was the top concern for 41 percent of voters in the midterm elections, but Congress does not have to wait until next year to pass bipartisan health legislation. Among the must-pass bills for the 2018 lame duck session should be legislation that...
Read more

New CMS Rule Threatens the Bipartisan Compromise to Protect Those with Preexisting Conditions

Aug 6, 2019 | Medicare Part D, News

In the wide ideological gulf between Democrat and Republican healthcare reform efforts — with “Medicare For All” at one end and a market-based system at the other — there has emerged one bipartisan point of agreement: Those with preexisting conditions must...
Read more
« Older Entries

Categories

  • Access
  • Advocacy
  • California
  • Comment Letters
  • Copay Accumulators
  • Copay Assistance
  • COVID-19
  • Drug Costs
  • FDA
  • Featured
  • Featured Action
  • Federal Issues
  • Health Insurance
  • Health Policy
  • ICER
  • Illinois
  • Issues
  • Letters Submitted
  • Letters Supported
  • Massachusetts
  • Medicaid
  • Medicare
  • Medicare Part D
  • News
  • Op-Ed
  • Out of Pocket Costs
  • Pharmacy Benefit Managers
  • Podcast
  • Prescription Drugs
  • Press Releases
  • Public Statement
  • QALY
  • State Issues
  • Statements
  • Step Therapy
  • Surprise Billing
  • Terry's Hot Take
  • Uncategorized
  • Value Based Insurance Design
  • Value Frameworks
  • Virtual Advocacy Chat

Tags

21st Century Cures Act 340B Access to Care Advocacy Alzheimer's Biden Administration biosimilars Cancer cms Copay Accumulators copay assistance COVID-19 Vaccine drug costs Drug Manufacturing Drug Pricing drug rebate fail first FDA Gene Therapies H.R.3 Health Insurance hospital bills HR 3708 hsa ICER Insurance design Joe Biden medicare Part B medicare part D Mental Health Nonmedical Switching open enrollment Out of Pocket Costs PBM PBMs pharmacy benefit managers Price Transparency Prior Authorization QALY Rare Disease Right to Repair Step Therapy Telehealth transparency Value Framework

Recent Posts

  • Rural Hospital Closures Further Complicates Healthcare Access in Mississippi
  • Contract Changes Leave DoD TRICARE Beneficiaries Without Pharmacy Access
  • Most Popular Podcast Episodes in 2022 From Patients Rising
  • Patients Rising Now Signs onto Letter to President on Alzheimer’s Scans
  • PRN and 17 Patient Groups Send Letter to Hill on Home Health Cuts

Get Updates In Your Inbox

Sign up for updates about our patient education, support and advocacy programs and initiatives.

YES, KEEP ME UPDATED

Patients Rising Now

We are a 501c4 group dedicated to demanding transparency in health care.  We are part of the Patients Rising suite of programs and services.

700 12th St. NW 700, Suite 700
Washington, DC 20005
202-679-8223

 

  • Privacy Policy
  • Sponsor Opportunities
  • Patients Rising
  • Patient Action Center
  • Facebook
  • Twitter
  • Instagram
All rights reserved. © 2023 Patients Rising Now